While more research is needed in this area, a study looking at GLP1 receptor agonist use and opioid overdose risk in patients with type 2 diabetes and opioid use disorder (OUD) found that semaglutide was associated with reduced opioid overdose risk in patients with comorbid T2D and OUD
[DOI] [PMC free article] [PubMed] [Google Scholar] 166.Jun L.S., Millican R.L., Hawkins E.D., Konkol D.L., Showalter A.D., Christe M.E
If youre uncertain about which supplement is right for you, we encourage you to take our AI quiz to determine the best options tailored to your wellness journey
One study reported a significant drop in the levels of PSA, while the other study failed to demonstrate a notable decrease in serum PSA
This blog post will review the BPC 157 literature and outline potential benefits of BPC 157
What is the best GLP-1 weight loss program for men in Chicago